New York Blood Center Enterprises is a global leader in blood group genotyping, advancing the science that makes transfusion medicine safer, more precise, and more equitable. With decades of pioneering research, NYBCe scientists have helped define the genetic basis of blood group diversity and have developed innovative tools that improve donor–recipient matching—especially for patients with complex serologic profiles or chronic transfusion needs.
NYBCe’s body of work includes landmark publications that shaped modern understanding of red cell antigen genetics, introduced high‑throughput genotyping into routine practice, and expanded knowledge of rare and variant alleles across diverse populations. These studies continue to guide clinical decision‑making, inform national and international standards, and support the development of next‑generation molecular testing.
As you explore the key publications below, you’ll see how NYBC’s research has consistently pushed the field forward—translating cutting‑edge genomics into real‑world impact for patients and healthcare providers.